<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for Merck &amp; Co., Inc. - Google Finance</title>
<description>News for Merck &amp; Co., Inc. - Google Finance</description>
<link>http://www.google.com/finance?q=NYSE:MRK&amp;amp;client=news-rss&amp;amp;ei=VhWbUdiRNuiy0AGbIQ</link>
<image>
<title>News for Merck &amp; Co., Inc. - Google Finance</title>
<url>/finance/s/M4XFgDr56u4/images/logo_us.gif</url>
<link>http://www.google.com/finance?q=NYSE:MRK&amp;amp;client=news-rss&amp;amp;ei=VhWbUdiRNuiy0AGbIQ</link>
</image>
<item>
<title>Cisco Systems, Inc. (CSCO), Merck &amp;amp; Co., Inc. (MRK), The Coca-Cola Company ...</title>
<link>http://www.insidermonkey.com/blog/cisco-systems-inc-csco-merck-co-inc-mrk-the-coca-cola-company-ko-will-these-stocks-stop-the-dows-record-run-today-145581/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982065750802</guid>
<pubDate>Mon, 20 May 2013 17:41:05 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/cisco-systems-inc-csco-merck-co-inc-mrk-the-coca-cola-company-ko-will-these-stocks-stop-the-dows-record-run-today-145581/&quot; style=&quot;font-size:1.2em&quot;&gt;Cisco Systems, Inc. (CSCO), Merck &amp;amp; Co., Inc. (MRK), The Coca-Cola Company ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;12 hours ago &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Merck &amp;amp; Co., Inc. (NYSE:MRK) has also dropped, falling 1.4% after the FDA expressed concerns about the side effects of the company&amp;#39;s suvorexant insomnia drug.&lt;/div&gt;
&lt;a href=&quot;http://www.nasdaq.com/article/market-close-report-nasdaq-composite-index-closes-at-349643-down-254-points-cm247331&quot;&gt;Market Close Report: NASDAQ Composite index closes at 3496.43 down -2.54 ...&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;NASDAQ&lt;/span&gt;&lt;br&gt;
&lt;a href=&quot;http://www.schaeffersresearch.com/commentary/content/ezines/stocks+little+changed+as+slow+news+day+draws+the+focus+to+the+fed/marketrecap.aspx?id=116182&quot;&gt;Stocks Little Changed as Slow News Day Draws the Focus to the Fed&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Schaeffers Research&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>MERCK &amp;amp; CO., INC. : FDA Staff : Merck Sleep Drug Effective; Safety Concerns ...</title>
<link>http://www.4-traders.com/MERCK-CO-INC-13611/news/Merck-Co-Inc-FDA-Staff-Merck-Sleep-Drug-Effective-Safety-Concerns-With-Higher-Doses-16896368/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982067457397</guid>
<pubDate>Mon, 20 May 2013 13:14:18 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/MERCK-CO-INC-13611/news/Merck-Co-Inc-FDA-Staff-Merck-Sleep-Drug-Effective-Safety-Concerns-With-Higher-Doses-16896368/&quot; style=&quot;font-size:1.2em&quot;&gt;MERCK &amp;amp; CO., INC. : FDA Staff : Merck Sleep Drug Effective; Safety Concerns ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;17 hours ago &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;WASHINGTON--Food and Drug Administration staff said a proposed sleep drug from Merck &amp;amp; Co. (MRK) was effective, but questioned the safety of the product&amp;#39;s higher doses.&lt;/div&gt;
&lt;a href=&quot;http://bostonherald.com/business/healthcare/2013/05/fda_has_safety_concerns_with_merck_insomnia_drug&quot;&gt;FDA has safety concerns on Merck insomnia drug&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Boston Herald&lt;/span&gt;&lt;br&gt;
&lt;a href=&quot;http://www.nasdaq.com/article/update-fda-staff-merck-sleep-drug-effective-but-some-dosage-concerns-20130520-01021&quot;&gt;FDA Staff: Merck Sleep Drug Effective but Some Dosage Concerns&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;NASDAQ&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Merck &amp;amp; Co., Inc. (MRK), Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN) - Pick ...</title>
<link>http://www.insidermonkey.com/blog/merck-co-inc-mrk-pfizer-inc-pfe-astrazeneca-plc-adr-azn-pick-your-poison-overweight-or-high-cholesterol-144668/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982067550808</guid>
<pubDate>Mon, 20 May 2013 14:57:20 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/merck-co-inc-mrk-pfizer-inc-pfe-astrazeneca-plc-adr-azn-pick-your-poison-overweight-or-high-cholesterol-144668/&quot; style=&quot;font-size:1.2em&quot;&gt;Merck &amp;amp; Co., Inc. (MRK), Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN) - Pick ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;15 hours ago &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Merck &amp;amp; Co., Inc. (NYSE:MRK) Overweight and have high cholesterol? You may have to pick one to work on at a time, according to data from the lab of John Thyfault, an associate professor of nutrition and exercise physiology at University of Missouri.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Merck &amp;amp; Co., Inc. Management Presents at UBS Global Healthcare Conference ...</title>
<link>http://seekingalpha.com/article/1447881-merck-amp-co-inc-management-presents-at-ubs-global-healthcare-conference-transcript?source=google_news</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982067924974</guid>
<pubDate>Mon, 20 May 2013 18:47:41 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://seekingalpha.com/article/1447881-merck-amp-co-inc-management-presents-at-ubs-global-healthcare-conference-transcript?source=google_news&quot; style=&quot;font-size:1.2em&quot;&gt;Merck &amp;amp; Co., Inc. Management Presents at UBS Global Healthcare Conference ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Seeking Alpha&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;11 hours ago &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;So good morning everybody, thanks for joining us for the conference. I am Marc Goodman, I cover large cap pharma and specialty pharma for UBS.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Merck &amp;amp; Co., Inc. (MRK), Illumina, Inc. (ILMN), GlaxoSmithKline plc (ADR) (GSK ...</title>
<link>http://www.insidermonkey.com/blog/merck-co-inc-mrk-illumina-inc-ilmn-glaxosmithkline-plc-adr-gsk-the-u-s-s-deadliest-diseases-144916/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982066439692</guid>
<pubDate>Mon, 20 May 2013 13:09:55 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/merck-co-inc-mrk-illumina-inc-ilmn-glaxosmithkline-plc-adr-gsk-the-u-s-s-deadliest-diseases-144916/&quot; style=&quot;font-size:1.2em&quot;&gt;Merck &amp;amp; Co., Inc. (MRK), Illumina, Inc. (ILMN), GlaxoSmithKline plc (ADR) (GSK ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;17 hours ago &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Merck &amp;amp; Co., Inc. (NYSE:MRK) There&amp;#39;s good news and bad news for Americans. The good news is that the age-adjusted death rate in the U.S.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Merck &amp;amp; Co., Inc. (MRK), Seadrill Ltd (SDRL), Banco Santander, S.A. (ADR ...</title>
<link>http://www.insidermonkey.com/blog/merck-co-inc-mrk-seadrill-ltd-sdrl-banco-santander-s-a-adr-san-heres-what-this-big-market-beater-has-been-buying-and-selling-142737/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.insidermonkey.com/blog/merck-co-inc-mrk-seadrill-ltd-sdrl-banco-santander-s-a-adr-san-heres-what-this-big-market-beater-has-been-buying-and-selling-142737/</guid>
<pubDate>Thu, 16 May 2013 20:27:53 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/merck-co-inc-mrk-seadrill-ltd-sdrl-banco-santander-s-a-adr-san-heres-what-this-big-market-beater-has-been-buying-and-selling-142737/&quot; style=&quot;font-size:1.2em&quot;&gt;Merck &amp;amp; Co., Inc. (MRK), Seadrill Ltd (SDRL), Banco Santander, S.A. (ADR ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 16, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Merck &amp;amp; Co., Inc. (NYSE:MRK) Every quarter, many money managers have to disclose what they&amp;#39;ve bought and sold, via &amp;quot;13F&amp;quot; filings.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Johnson &amp;amp; Johnson (JNJ), Merck &amp;amp; Co., Inc. (MRK) &amp;amp; What To Watch</title>
<link>http://www.insidermonkey.com/blog/johnson-johnson-jnj-merck-co-inc-mrk-what-to-watch-141287/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982060715080</guid>
<pubDate>Tue, 14 May 2013 16:51:40 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/johnson-johnson-jnj-merck-co-inc-mrk-what-to-watch-141287/&quot; style=&quot;font-size:1.2em&quot;&gt;Johnson &amp;amp; Johnson (JNJ), Merck &amp;amp; Co., Inc. (MRK) &amp;amp; What To Watch&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 14, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Johnson &amp;amp; Johnson (NYSE:JNJ) Pharmaceutical companies in the U.S. are not having it easy these days. When Johnson &amp;amp; Johnson (NYSE:JNJ) reported its latest numbers recently, it suffered from currency headwinds.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>MERCK &amp;amp; CO., INC. : Merck to Present at the UBS Global Healthcare Conference</title>
<link>http://www.4-traders.com/MERCK-CO-INC-13611/news/Merck-Co-Inc-Merck-to-Present-at-the-UBS-Global-Healthcare-Conference-16870629/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982062407031</guid>
<pubDate>Fri, 17 May 2013 19:52:50 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/MERCK-CO-INC-13611/news/Merck-Co-Inc-Merck-to-Present-at-the-UBS-Global-Healthcare-Conference-16870629/&quot; style=&quot;font-size:1.2em&quot;&gt;MERCK &amp;amp; CO., INC. : Merck to Present at the UBS Global Healthcare Conference&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 17, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Peter N. Kellogg, executive vice president and chief financial officer, Merck, is scheduled to present at the UBS Global Healthcare Conference in New York City ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>MERCK &amp;amp; CO., INC. : Merck Prices $ 6.5 Billion Debt Offering</title>
<link>http://www.4-traders.com/MERCK-CO-INC-13611/news/Merck-Co-Inc-Merck-Prices-$-6-5-Billion-Debt-Offering-16865397/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982062983016</guid>
<pubDate>Wed, 15 May 2013 22:31:29 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/MERCK-CO-INC-13611/news/Merck-Co-Inc-Merck-Prices-$-6-5-Billion-Debt-Offering-16865397/&quot; style=&quot;font-size:1.2em&quot;&gt;MERCK &amp;amp; CO., INC. : Merck Prices $ 6.5 Billion Debt Offering&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 15, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Merck &amp;amp; Co., Inc. : Merck Prices $ 6.5 Billion Debt Offering. 05/15/2013| 06:30pm US/Eastern. Recommend: 0. Merck &amp;amp; Co., Inc. priced today a $6.5 billion public offering of senior unsecured notes. The notes include: $1,000 million of 0.70% notes due ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Merck &amp;amp; Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to ...</title>
<link>http://www.marketwatch.com/story/merck-co-inc-and-pfizer-enter-worldwide-collaboration-agreement-to-develop-and-commercialize-ertugliflozin-an-investigational-medicine-for-type-2-diabetes-2013-04-29</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778137850432</guid>
<pubDate>Mon, 29 Apr 2013 11:30:48 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.marketwatch.com/story/merck-co-inc-and-pfizer-enter-worldwide-collaboration-agreement-to-develop-and-commercialize-ertugliflozin-an-investigational-medicine-for-type-2-diabetes-2013-04-29&quot; style=&quot;font-size:1.2em&quot;&gt;Merck &amp;amp; Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;MarketWatch (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 29, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;WHITEHOUSE STATION, N.J. &amp;amp; NEW YORK, Apr 29, 2013 (BUSINESS WIRE) -- Merck &amp;amp; Co., Inc. (NYSE:MRK) , known as MSD outside the United States and Canada (&amp;quot;Merck&amp;quot;), and Pfizer Inc. (NYSE:PFE) today announced that they have entered into a ...&lt;/div&gt;
&lt;a href=&quot;http://www.businessweek.com/ap/2013-04-29/earnings-preview-merck-to-key-on-coming-new-drugs&quot;&gt;Earnings Preview: Merck to key on coming new drugs&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Businessweek&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
